Upstream Bio Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Upstream Bio Inc
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Upstream Bio Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Upstream Bio Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Upstream Bio Inc is UPB:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Upstream Bio Inc has its primary listing on NASDAQ. You can trade Upstream Bio Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Upstream Bio Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Upstream Bio Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Upstream Bio Inc.